NTVH - jaargang 19, nummer 6, september 2022
dr. I. Spaan
Op 28 april 2022 promoveerde Ingrid Spaan aan de Universiteit Utrecht op haar proefschrift, getiteld ‘Targeting pro-survival cell signaling pathways in multiple myeloma, personalized treatment for newly-diagnosed and relapsed-refractory patients’, onder begeleiding van promotoren prof. dr. M.C. Minnema en prof. dr. M.M. Maurice, en copromotoren dr. V. Peperzak en dr. R.A.P. Raijmakers. De belangrijkste bevindingen van het proefschrift worden hier besproken. Het volledige proefschrift kan worden bekeken via https://dspace.library.uu.nl/handle/1874/416597
(NED TIJDSCHR HEMATOL 2022;19:302–4)
Lees verderTo provide the best experiences, we and our partners use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us and our partners to process personal data such as browsing behavior or unique IDs on this site and show (non-) personalized ads. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Click below to consent to the above or make granular choices. Your choices will be applied to this site only. You can change your settings at any time, including withdrawing your consent, by using the toggles on the Cookie Policy, or by clicking on the manage consent button at the bottom of the screen.